Director/PDMR Shareholding

Summary by AI BETAClose X

John Mackie, a Director of The Schiehallion Fund Limited, has notified the market of a sale of 14,709 ordinary shares at a price of $2.18 per share on October 6, 2026, on the London Stock Exchange. This initial notification represents an aggregated sale of the specified volume at the stated price.

Disclaimer*

Schiehallion Fund Limited (The)
07 October 2026
 

THE SCHIEHALLION FUND LIMITED

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

John Mackie

 

2

Reason for the notification

 

a)

Position/status

 

Director of The Schiehallion Fund Limited

b)

 

Initial notification /Amendment

Initial notification

 

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

The Schiehallion Fund Limited

b)

LEI

213800NQOLJA1JCWXQ56 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of no par value 

 

 

 

 

GG00BJ0CDD21

b)

Nature of the transaction

Sale of Shares

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

 $2.18

14,709

 

 

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

14,709

 

$2.18

 

e)

Date of the transaction

6 October 2026

 

 

f)

Place of the transaction

London Stock Exchange

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings